SCHEMBL28947358

SCHEMBL28947358

FC(F)(F)c1ccc(C2(F)CCNC2)cc1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAOA P21397 2/20 0.44
MAOB P27338 2/20 0.44
KDM1A O60341 1/20 0.44
SLC6A3 Q01959 3/20 0.40
OPRM1 P35372 1/20 0.40
OPRL1 P41146 1/20 0.40
TACR1 P25103 1/20 0.40
HTR2C P28335 2/20 0.40
DAO P14920 1/20 0.38
RORC P51449 4/20 0.37
SLC6A4 P31645 2/20 0.37
SLC6A2 P23975 1/20 0.37
NR1I2 O75469 2/20 0.36
NR1H3 Q13133 1/20 0.36
OPRD1 P41143 1/20 0.36
OPRK1 P41145 1/20 0.36
KCNH2 Q12809 1/20 0.36
P2RY14 Q15391 1/20 0.35
APP P05067 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4890866 0.87 HTR2C (0.47) MAOAMAOBKDM1ASLC6A3OPRM1
SCHEMBL17729483 0.85 MAOA (0.50) MAOAMAOBKDM1ASLC6A3OPRM1
SCHEMBL28947779 0.79 SLC6A3 (0.43) MAOAMAOBSLC6A3OPRM1TACR1
Hydrochloric Acid SCHEMBL31412616 0.78 SLC6A3 (0.42) MAOAMAOBSLC6A3TACR1DAO
SCHEMBL1814719 0.77 DRD2 (0.47) MAOAMAOBKDM1ASLC6A3OPRM1
SCHEMBL15819350 0.77 HTR2A (0.59) MAOAMAOBSLC6A3OPRM1TACR1
SCHEMBL28122494 0.73 HTR2C (0.44) MAOAMAOBKDM1ASLC6A3OPRM1
SCHEMBL27100094 0.73 OPRM1 (0.45) MAOAMAOBKDM1ASLC6A3OPRM1
SCHEMBL653874 0.73 DRD2 (0.59) MAOAMAOBKDM1ASLC6A3OPRM1
Hydrochloric Acid SCHEMBL17224460 0.72 HTR2A (0.45) MAOAMAOBKDM1ASLC6A3OPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115698009-A CD73 inhibiting 2,4-dioxopyrimidine compounds 吉利德科学公司 2023-02-03 CN disclosed